Meta Platforms
META
Taiwan Semiconductor
TSM
Amazon
AMZN
Apple
AAPL
NVIDIA
NVDA
US Stock MarketDetailed Quotes
RIGL Rigel Pharmaceuticals
- 27.050
- 0.0000.00%
Close Dec 3 16:00 ET
- 27.050
- 0.0000.00%
Post 16:02 ET
476.49MMarket Cap100.19P/E (TTM)
27.870High26.330Low143.48KVolume26.810Open27.050Pre Close3.86MTurnover0.96%Turnover RatioLossP/E (Static)17.62MShares29.82052wk High-32.55P/B404.19MFloat Cap7.48452wk Low--Dividend TTM14.94MShs Float1147.499Historical High--Div YieldTTM5.69%Amplitude6.400Historical Low26.894Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Rigel Pharmaceuticals Stock Forum
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
25.+
Go, Go, Go!!!
No comment yet